Ocrevus Injection
Product Images NDC 50242-150

3 FDA label images from Genentech, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ocrevus (NDC 50242-150). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Genentech, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1 (Ocrevus 01)

Figure 1 (Ocrevus 01)
A Kaplan-Meier curve showing the proportion of patients having confirmed disability progression over time for two treatment groups: REBIF 44 mcg and EVUS 600 mg. The graph includes patient counts at risk at various time points and indicates a 40% reduction in risk of progression with EVUS compared to REBIF, with corresponding hazard ratio and p-value.*
FDA Label Image

Figure 2 (Ocrevus 02)

Figure 2 (Ocrevus 02)
A Kaplan-Meier survival curve showing the proportion of patients having confirmed disability progression over time for placebo (n=244) and EVUS 600 mg (n=488). The graph illustrates a lower risk of disability progression in the EVUS group compared to placebo, with a reported 24% risk reduction and hazard ratio (HR) of 0.76 (95% CI: 0.59 to 0.98; p=0.0321). Patient numbers at risk are provided at multiple time points from baseline through week 216.*
FDA Label Image

Principal Display Panel (300 mg/10 mL Vial Carton)

Principal Display Panel (300 mg/10 mL Vial Carton)
Label for EVUS (ocrelizumab) injection, 300 mg/10 mL (30 mg/mL) in a single-dose vial. The product is indicated for intravenous infusion and must be diluted before use. The label includes NDC 50242-150-01 and is distributed by Genentech, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.